Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers

Abstract

The complex genomic landscape of RAS-mutant tumors is reflective of selection processes in a cancer lineage-specific and context-dependent manner, highlighting differential therapeutic vulnerabilities that can be clinically translated.